Obiettivo
T-CIA will investigate basic processes of physiological ageing of human T lymphocytes. Partners will contribute samples from young and old, very healthy and less healthy donors, and in vitro cultured cells, which will be redistributed for analysis using proteomics, genomics, DNA damage and repair assessment, antigen receptor repertoire, T cell surface markers and function, apoptosis and proliferation control, and immunogenetic studies. Biomarkers selected as relevant to immune ageing rather than resulting from underlying disease or culturing will be recommended for monitoring intervention studies. T-CIA interventions will be on T cell clones is tissue culture, using anti-oxidants, antisense approaches, h-TERT and HSP gene transfection, cytokine and hormone cocktails etc., and will result in recommendations for in vivo intervention. Biomarker monitoring and anti-ageing interventions are potentially marketable by the industrial partner.
Campo scientifico
Invito a presentare proposte
Data not availableMeccanismo di finanziamento
CSC - Cost-sharing contractsCoordinatore
72072 TUEBINGEN
Germania